[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.130.145. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 100
Citations 0
Comment & Response
November 2015

The True Environmental Cost of Chlorofluorocarbon-Based Inhalers

Author Affiliations
  • 1Pulmonary and Critical Care Medicine, VA Puget Sound Health Care System, University of Washington, Seattle
JAMA Intern Med. 2015;175(11):1867. doi:10.1001/jamainternmed.2015.5237

To the Editor It was with apprehension that I read the interesting and sobering analysis by Jena et al1 and commentaries2,3 on the health care and/or cost consequences of the decision of the US Food and Drug Administration (FDA) to ban chlorofluorocarbon (CFC)-based metered-dose inhalers (MDI) in order for the United States to comply fully with the Montreal Protocol. I participated as a panel member of the FDA advisory committee meeting in 2004 and chaired a follow-up meeting in 2005 convened to discuss the issues ahead of their final ruling later that year.

First Page Preview View Large
First page PDF preview
First page PDF preview
×